Abstract
Background
Recently, more and more evidence indicated that the long non-coding RNA was strictly related to the occurrence and progression of human cancers, including esophageal cancer (EC). We observed that LINC00667 was increased in EC, but the function of LINC00667 was unclear. Therefore, the function and potential molecular mechanism of LINC00667 in the progression of EC need to be further studied.
Methods
Quantitative real-time PCR was used to investigate the levels of LINC00667, miR-200b-3p, and SLC2A3. The levels of protein involved in cell cycle, cell apoptosis, epithelial–mesenchymal transition, as well as SLC2A3 were quantitatived by western blot. The role of LINC00667 in the proliferative, migratory and invasive capabilities of EC cells were measured by cell counting kit-8 assay, EdU assay, flow cytometry assay, wound healing assay and transwell assay, respectively. Interaction between LINC00667 and miR-200b-3p or miR-200b-3p and SLC2A3 were confirmed using a luciferase reporter assay.
Results
In this work, we found that LINC00667 expression was up-regulated in EC cell lines, and LINC00667 knockdown inhibited cell proliferation, migration, and invasion in EC cells. In addition, it showed that LINC00667 functioned as competitive endogenous RNA for miR-200b-3p by the DIANA-LncBase database. Moreover, we used targetscan online software to predict SLC2A3 as a target gene of miR-200b-3p. Subsequently, rescue experiments confirmed that knocking out SLC2A3 could reverse the inhibitory effect of miR-200b-3p on EC cells transfected with sh-LINC00667.
Conclusion
Herein, we revealed the novel mechanism of LINC00667 on regulating metastasis-related gene by sponge regulatory axis during EC metastasis. Our results demonstrated that LINC00667 plays a critical role in metastatic EC by mediating sponge regulatory axis miR-200b-3p/SLC2A3. To explore function of LINC00667/miR-200b-3p/SLC2A3 axis may provide an informative biomarker of malignancy and a highly selective anti-EC therapeutic target.
Similar content being viewed by others
Data availability
The raw data required to reproduce these findings cannot be shared at this time as the data also forms part of an ongoing study.
Abbreviations
- EC:
-
Esophageal cancer
- EMT:
-
Epithelial–mesenchymal transition
- CCK-8:
-
Cell counting kit-8
- ceRNA:
-
Competitive endogenous RNA
- GLUT:
-
Glucose transporter
References
Alaei S, Sadeghi B, Najafi A, Masoudi-Nejad A. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma. Genomics. 2019;111:76–89. https://doi.org/10.1016/j.ygeno.2018.01.003.
Ancey PB, Contat C, Meylan E. Glucose transporters in cancer—from tumor cells to the tumor microenvironment. FEBS J. 2018;285:2926–2943. https://doi.org/10.1111/febs.14577.
Chen D, Wang H, Chen J et al. MicroRNA-129-5p regulates glycolysis and cell proliferation by targeting the glucose transporter SLC2A3 in gastric cancer cells. Front Pharmacol. 2018;9:502. https://doi.org/10.3389/fphar.2018.00502.
Chen J, Kwong DL, Cao T et al. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Dis Esophagus. 2015;28:84–89. https://doi.org/10.1111/dote.12088.
Chen M-J, Deng J, Chen C, Hu W, Yuan Y-C, Xia Z-K. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. Int J Biochem Cell Biol. 2019;113:27–36. https://doi.org/10.1016/j.biocel.2019.05.011.
Chu J, Li H, Xing Y et al. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Biomed Pharmacother. 2019;116:109029. https://doi.org/10.1016/j.biopha.2019.109029.
Codipilly DC, Qin Y, Dawsey SM et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018;88:413–426. https://doi.org/10.1016/j.gie.2018.04.2352.
Deng D, Sun P, Yan C et al. Molecular basis of ligand recognition and transport by glucose transporters. Nature. 2015;526:391–396. https://doi.org/10.1038/nature14655.
Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–7943. https://doi.org/10.3748/wjg.v21.i26.7933.
Grote P, Boon RA. LncRNAs coming of age. Circ Res. 2018;123:535–537. https://doi.org/10.1161/CIRCRESAHA.118.313447.
Huang T-X, Fu L. The immune landscape of esophageal cancer. Cancer Commun. 2019;39:79. https://doi.org/10.1186/s40880-019-0427-z.
Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gener Thorac Cardiovasc Surg. 2013;61:330–335. https://doi.org/10.1007/s11748-013-0246-0.
Kennedy BM, Harris RE. Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer. Inflammopharmacology. 2018. https://doi.org/10.1007/s10787-018-0489-6.
Koutsioumpa M, Hatziapostolou M, Polytarchou C et al. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming. Gut. 2019;68:1271–1286. https://doi.org/10.1136/gutjnl-2017-315690.
Liu P, Chen S, Huang Y et al. LINC00667 promotes Wilms’ tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β. Cell Biol Int. 2020;44:1382–1393. https://doi.org/10.1002/cbin.11334.
Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202–1207. https://doi.org/10.1016/j.jaci.2017.08.034.
Lv Z, Wei J, You W et al. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. J Transl Med. 2017;15:257. https://doi.org/10.1186/s12967-017-1357-7.
Ma H-W, Xi D-Y, Ma J-Z et al. Long noncoding RNA AFAP1-AS1 promotes cell proliferation and metastasis via the miR-155-5p/FGF7 axis and predicts poor prognosis in gastric cancer. Dis Mark. 2020;2020:8140989. https://doi.org/10.1155/2020/8140989.
Ma J, Xiao Y, Tian B et al. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. J Cell Biochem. 2020;121:1374–1387. https://doi.org/10.1002/jcb.29373.
Mao Y, Fu Z, Zhang Y et al. A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma. Sci Rep. 2018;8:8823. https://doi.org/10.1038/s41598-018-27307-2.
Militello G, Weirick T, John D, Döring C, Dimmeler S, Uchida S. Screening and validation of lncRNAs and circRNAs as miRNA sponges. Brief Bioinform. 2017;18:780–788. https://doi.org/10.1093/bib/bbw053.
Moghbeli M, Mosannen Mozaffari H, Memar B et al. Role of MAML1 in targeted therapy against the esophageal cancer stem cells. J Transl Med. 2019;17:126. https://doi.org/10.1186/s12967-019-1876-5.
Peng L, Cheng S, Lin Y et al. CCGD-ESCC: a comprehensive database for genetic variants associated with esophageal squamous cell carcinoma in Chinese population. Genomics Proteom Bioinform. 2018;16:262–268. https://doi.org/10.1016/j.gpb.2018.03.005.
Peng W, Si S, Zhang Q et al. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J Exp Clin Cancer Res. 2015;34:79. https://doi.org/10.1186/s13046-015-0197-7.
Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Phys. 2017;95:22–28.
Smyth EC, Lagergren J, Fitzgerald RC et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. https://doi.org/10.1038/nrdp.2017.48.
Tong YS, Wang XW, Zhou XL et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14:3. https://doi.org/10.1186/1476-4598-14-3.
Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48:1647–1653.
Wang P-S, Chou C-H, Lin C-H et al. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Oncogene. 2018;37:4662–4678. https://doi.org/10.1038/s41388-018-0293-1.
Watanabe M, Otake R, Kozuki R et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020;50:12–20. https://doi.org/10.1007/s00595-019-01878-7.
Xu LJ, Yu XJ, Wei B et al. LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis. Eur Rev Med Pharmacol Sci. 2018;22:2653–2661. https://doi.org/10.26355/eurrev_201805_14961.
Zhang F, Zhang M. Oleuropein inhibits esophageal cancer through hypoxic suppression of BTG3 mRNA. Food Funct. 2019;10:978–985. https://doi.org/10.1039/c8fo02223b.
Zhang H, Hua Y, Jiang Z et al. Cancer-associated fibroblast-promoted LncRNA confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma. Clin Cancer Res. 2019;25:1989–2000. https://doi.org/10.1158/1078-0432.CCR-18-0773.
Zhang L, Chen J, Wang L et al. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer. J Cell Biochem. 2019;120:19345–19357. https://doi.org/10.1002/jcb.28699.
Zhang Z-W, Chen J-J, Xia S-H et al. Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2. Gene. 2018;650:60–67. https://doi.org/10.1016/j.gene.2018.01.096.
Acknowledgments
We deeply appreciate the support by all participants.
Funding
No funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pan, J., Zang, Y. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis. Dig Dis Sci 67, 2936–2947 (2022). https://doi.org/10.1007/s10620-021-07145-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-021-07145-5